• If you are wondering whether Molina Healthcare's current share price reflects its true worth, this breakdown is designed to help you connect the stock's recent moves with what you might actually be paying for.
• The stock last closed at US$192.70, with returns of 9.5% over 7 days and 41.9% over 30 days, set against an 8.0% year to date result and a 39.4% decline over the past year.
• Recent headlines around Molina Healthcare have focused on the business as a managed care player in the US healthcare sector, with attention on how its positioning and contracts could affect long term prospects. These stories have shaped how investors think about both the recent rebound in the share price and the risks that the longer term return profile, including a 35.7% 3 year and 28.1% 5 year decline, might be signalling.
• Molina Healthcare currently has a valuation score of 2 out of 6, and the sections that follow will walk through standard valuation approaches before finishing with a broader way to think about what that score really means for you as an investor.

Molina Healthcare scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Molina Healthcare Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes estimates of the cash a business may generate in the future, then discounts those cash flows back to today using a required return, to arrive at an estimated value per share.

For Molina Healthcare, the model used is a 2 Stage Free Cash Flow to Equity approach, working off last twelve months free cash flow of about $254.8 million and a series of projected free cash flows out to 2035. Analyst inputs cover the earlier years, and Simply Wall St extrapolates further out, with projected free cash flow of $1.2 billion in 2030. All cash flows and the terminal value are then discounted back to today.

This process gives an estimated intrinsic value of $642.04 per share, compared with the recent share price of $192.70. On this basis, the DCF output suggests the shares trade at roughly a 70.0% discount to that intrinsic value, which indicates that the stock screens as heavily undervalued on this model alone.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Molina Healthcare is undervalued by 70.0%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Molina Healthcare Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about what you are paying for each dollar of earnings, and it often captures how the market weighs both business quality and earnings power in a single number.

What counts as a normal or fair P/E often reflects expectations about future growth and the level of risk you are taking on. Higher growth and lower perceived risk typically justify a higher multiple, while the opposite can pull it down.

Molina Healthcare currently trades on a P/E of 53.39x, compared with the Healthcare industry average of 24.86x and a peer average of 24.38x, so the stock sits well above these simple benchmarks.

Simply Wall St also calculates a Fair Ratio, which in this case is 42.54x. This is a proprietary estimate of what the P/E could look like after considering factors such as earnings growth, industry, profit margins, market cap and company specific risks.

Because the Fair Ratio blends these elements, it can give you a more tailored anchor point than a basic comparison with peers or an industry average, which do not adjust for differences in risk or profitability.

Comparing the current P/E of 53.39x with the Fair Ratio of 42.54x suggests the shares trade at a premium to that fair range.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your Molina Healthcare Narrative

Earlier it was mentioned that there is an even better way to understand valuation, and on Simply Wall St that starts with Narratives, where you spell out your story for Molina Healthcare and tie it directly to assumptions about future revenue, earnings, margins and a fair value that can then be compared with the current price.

Each Narrative links the company’s business story to a forecast and then to a fair value estimate, all within an accessible tool on the Simply Wall St Community page that millions of investors use to set their own view rather than relying only on headline ratios like P/E.

For Molina Healthcare, one investor might align with a higher fair value around US$411.65 based on assumptions such as 7.42% revenue growth, a 5.0% profit margin and a future P/E of 13.4x. Another might lean toward a lower fair value around US$109.00 built on 1.74% revenue growth, a 0.99% margin and a future P/E of 12.89x. As new earnings, news or guidance are added on Simply Wall St, those Narratives update so you can quickly reassess whether the gap between your fair value and the live market price points to a buy, hold or sell decision for your own portfolio.

For Molina Healthcare, however, we will make it really easy for you with previews of two leading Molina Healthcare Narratives:

Fair value in this bullish Narrative: US$411.65 per share

Implied discount to that fair value at the last close: about 53.2%

Revenue growth assumption used in this Narrative: 7.42%

• Focuses on membership growth, Medicare expansion and a pipeline of contracts and acquisitions as key business drivers.
• Highlights regulatory risk, competition, medical cost control and Medicaid redeterminations as important pressure points to watch.
• Works off revenue and earnings projections that support a higher fair value than the current share price on a P/E based view.

Fair value in this cautious Narrative: US$149.76 per share

Implied premium to that fair value at the last close: about 28.6%

Revenue growth assumption used in this Narrative: 4.11%

• Emphasises that recent contract wins, rate moves and acquisitions could still support earnings, but only if medical costs stay contained.
• Flags risks around Medicaid funding, Marketplace program changes, contract churn and higher medical costs as potential constraints on earnings stability.
• Uses analyst assumptions for revenue, margins, share count and a future P/E to arrive at a fair value close to the consensus target.

If you want to weigh these viewpoints against your own expectations for contracts, margins and regulation, it helps to see how other investors are joining the dots between the story and the numbers in one place. That is where the community Narratives come in, starting with See what the community is saying about Molina Healthcare.

Do you think there's more to the story for Molina Healthcare? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.